Evidence map›Paper›PMID 42367572›Full record

ArticleCureus2026

Youth and Young Adult National Overdose Rates: A Descriptive, Ecological Cross-Sectional Time-Trend Analysis of Drug Overdose Mortality in 10-24-Year-Olds in the United States.

Jane Wakefield, Chris Sun, Sina Ramtin, Anthony Castro, Asif M Ilyas

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jane WakefieldOpioid Research and Education, Drexel University College of Medicine, Philadelphia, USA.
Chris SunOpioid Research and Education, Rothman Institute Foundation for Opioid Education and Research, Philadelphia, USA.
Sina RamtinOpioid Research and Education, Rothman Institute Foundation for Opioid Research and Education, Philadelphia, USA.
Anthony CastroOpioid Research and Education, Rothman Institute Foundation for Opioid Research and Education, Philadephia, USA.
Asif M IlyasOpioid Research and Education, Rothman Institute Foundation for Opioid Research and Education, Philadelphia, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction Drug overdose (OD) mortality continues to be a public health crisis in the United States (US). The ongoing fourth wave of the opioid crisis necessitates continued monitoring of contemporary drug OD trends, particularly among vulnerable populations, such as the youth and young adults (YYAs) aged 10-24 years old. Furthermore, the COVID-19 pandemic may have exacerbated the opioid crisis in this specific population, warranting further investigation. Thus, understanding the current dynamics of drug OD among YYAs can offer descriptive data to inform targeted intervention and resource allocation. As such, this ecological cross-sectional time-trend analysis aims to evaluate OD trends among those aged 10-24 years in the US from 2018 to 2023, with additional analyses focusing on region, race and ethnicity, and sex-specific trends. This study hypothesized that while OD death rates may have declined since the peak of the COVID-19 pandemic, current rates are still higher than pre-pandemic rates. Methods A primary query using the United States Centers for Disease Control and Prevention's (CDC) Wide-ranging ONline Data for Epidemiologic Research (WONDER) database yielded underlying cause of death data for those aged 10 to 24 years due to unintentional drug OD between 2018 and 2023. OD death rates per 100,000 were then analyzed by US geographical divisions and regions, race, ethnicity, and sex. For analysis, non-inferential, descriptive statistics were used. Crude OD rates were presented with 95% confidence intervals. Results Unintentional OD deaths peaked during the COVID-19 pandemic, and across the majority of the country, rates continue to be higher post-pandemic than pre-pandemic. Although the YYA OD death rate rose sharply between 2019 and 2020 from 6.6 [6.4-6.8] to 10.3 [10.1-10.6] per 100,000 individuals, the rate peaked at 10.5 [10.3-10.8] per 100,000 in 2021. While declining since 2021, the OD mortality rate remained higher in 2023 (8.3 [8.1-8.5]) than in 2018 (6.4 [6.2-6.6]) and 2019 (6.6 [6.4-6.8]). YYA males overall had higher rates of OD, yet the percent changes of OD death rates were higher among YYA females across most census divisions from the pre-pandemic period to the peri/post-pandemic period. Furthermore, American Indian and Alaska Native (AI/AN) YYAs were particularly impacted, with males and females experiencing an increase in OD death rate from 8.7 [7.0-10.7] pre-pandemic to 14.5 [12.8-16.1] peri/post-pandemic and 3.5 [2.4-4.9] pre-pandemic to 9.1 [7.7-10.4] peri/post-pandemic, respectively. Black or African American YYAs similarly exhibited an over twofold increase in crude OD death rate, from 5.5 [5.0-5.9] pre-pandemic to 13.2 [12.6-13.7] peri/post-pandemic for males, and from 2.5 [2.2-2.8] pre-pandemic to 6.2 [5.9-6.6] peri/post-pandemic for females. Conclusion Youth and young adults continue to be impacted by the ongoing opioid crisis and drug OD, highlighting an ongoing public health concern that must be addressed. Rates of unintentional OD deaths remain elevated above pre-pandemic levels despite decreasing since the peak of the pandemic. Addressing current OD trends among YYAs populations can maximize population-specific resource allocation, in hopes of reducing preventable, unintentional deaths among this vulnerable population.

Indexed as

center for disease controlcovid-19drug overdoseoverdose preventionpediatric overdosepublic health research

Identifiers

PMID42367572
PMCPMC13296722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.